| Literature DB >> 28204847 |
Brigitte Wendl1, A Kamenica2, H Droschl2, N Jakse2, F Weiland3,4, T Wendl5, M Wendl5.
Abstract
OBJECTIVES: Despite recommendations for early treatment of hereditary Angle Class III syndrome, late pubertal growth may cause a relapse requiring surgical intervention. This study was performed to identify predictors of successful Class III treatment.Entities:
Keywords: Chincup; Class III therapy; Prognostic parameters; Treatment success
Mesh:
Year: 2017 PMID: 28204847 PMCID: PMC5343075 DOI: 10.1007/s00056-016-0075-8
Source DB: PubMed Journal: J Orofac Orthop ISSN: 1434-5293 Impact factor: 1.938
Fig. 1Analysis of the lateral cephalogram with 37 evaluated parameters (linear and angular measurements)
Abb. 1 Fernröntgenseitenbildanalyse mit den 37 ausgewerteten Parametern (lineare und Winkelmessungen)
Descriptive statistical pretreatment (T0), posttreatment (T1) and 25-years follow-up (T2) data obtained in the success versus failure group for the 37 cephalometric parameters measured
Tab. 1 Deskriptive Statistik der 37 Fernröntgenwerte in der Erfolgs- und in der Misserfolgsgruppe zu den Zeitpunkten T0 (vor Therapie), T1 (nach Therapie) und T2 (25 Jahre nach Therapie)
| Wits (mm) | Pretreatment values ( | Posttreatment values ( | 25-year follow-up ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Failure | Success | Failure | Success | Failure | Success | |||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| −4 | 3.54 | −2.83 | 2.7 | −2.43 | 2.51 | −1.83 | 2.71 | −2.57 | 3.16 | −2.89 | 3.45 | |
| GH (%) | 61.29 | 1.89 | 62.5 | 3.33 | 65.71 | 4.07 | 64.17 | 6.6 | 69.57 | 1.99 | 67.61 | 5.39 |
| SNA | 76.71 | 3.77 | 78.17 | 3.26 | 79 | 1.53 | 78.44 | 4.27 | 81 | 3.32 | 78.67 | 4.65 |
| SNB (°) | 78.5 | 2.5 | 77.29 | 2.87 | 79.29 | 3.35 | 78.22 | 4.26 | 83 | 4.62 | 79.83 | 3.87 |
| ANB (°) | 2.43 | 1.72 | 1.56 | 1.34 | 3 | 1.83 | 1.78 | 1.56 | 3.43 | 2.76 | 1.83 | 2.18 |
| Go (°) | 133.14 | 4.49 | 130 | 5.42 | 128.86 | 5.73 | 125 | 6.89 | 123.43 | 5.97 | 123.06 | 6.05 |
| Börk’s sum (°) | 395.71 | 3.25 | 394.22 | 4.85 | 378.13 | 40.55 | 388.11 | 24.3 | 388.43 | 6.5 | 387.61 | 18.24 |
| Gn/SN (°) | 67.86 | 4.53 | 65.56 | 3.05 | 66 | 2.71 | 65.61 | 5.15 | 63.29 | 4.03 | 65.78 | 3.28 |
| Spp-Spa (mm) | 48.14 | 2.79 | 47.67 | 4.27 | 50 | 3.83 | 51.22 | 3.77 | 54.72 | 2.23 | 56.57 | 4.75 |
| Cond-A (mm) | 78.24 | 4.75 | 80.29 | 4.97 | 83.65 | 5.26 | 86.43 | 5.31 | 89.11 | 4.41 | 92.14 | 4.69 |
| Cond-Gn (mm) | 112.29 | 10.09 | 108.24 | 6.63 | 124.57 | 12.11 | 118 | 8.97 | 135.14 | 13.83 | 126.56 | 9.65 |
| MM differential (mm) | 32 | 9.5 | 29.29 | 6.25 | 38.14 | 8.63 | 33.06 | 6.96 | 41.57 | 13.39 | 38.11 | 9.37 |
| S–N (mm) | 67.61 | 4.81 | 68.14 | 3.52 | 70.5 | 4.31 | 71.57 | 3.67 | 74.61 | 4.49 | 75.14 | 3.97 |
| Max:MandOccP | 0.64 | 0.45 | 0.72 | 0.32 | 0.38 | 0.48 | 0.52 | 0.28 | 0.28 | 0.29 | 0.35 | 0.23 |
| Go-Me (mm) | 63.57 | 4.69 | 62.94 | 7.34 | 72.71 | 8.48 | 70.22 | 6.57 | 80.86 | 6.52 | 76.06 | 5.32 |
| MaxP/MandP (°) | 27 | 3.37 | 27.5 | 5.09 | 24.29 | 5.06 | 24.44 | 4.95 | 18.86 | 4.1 | 23.17 | 4.82 |
| MaxP/SN (°) | 9.43 | 1.9 | 7.33 | 2.28 | 8.29 | 3.04 | 7.72 | 3.21 | 7.86 | 2.12 | 8.11 | 2.61 |
| Go-Me/SN (°) | 35.86 | 2.79 | 34.94 | 4.21 | 32.43 | 3.95 | 32.94 | 6.8 | 24.29 | 4.5 | 30.72 | 5.38 |
| Ar-Go (mm) | 40.14 | 3.18 | 38.22 | 3.49 | 48.14 | 6.34 | 42.67 | 4.93 | 56.14 | 4.56 | 49.28 | 4.84 |
| AB/MandP (°) | 66.71 | 5.94 | 66.33 | 4.16 | 67.29 | 5.62 | 69.17 | 4.6 | 66.71 | 9.32 | 67.33 | 5.31 |
| Cond-Pog/FH (°) | 39.71 | 3.99 | 40.35 | 4.01 | 42.57 | 3.78 | 42.75 | 3.91 | 42.71 | 4.68 | 43.76 | 2.97 |
| APDI (°) | 90.43 | 7.7 | 85.53 | 3.41 | 88.57 | 7.21 | 85 | 4.43 | 94.86 | 6.67 | 89.53 | 4.12 |
| Me-Go-N (°) | 73.71 | 2.93 | 69.83 | 16.02 | 73.14 | 5.46 | 72.78 | 4.28 | 71.43 | 5.47 | 72.61 | 4.1 |
| FH/S-Gn (°) | 51.71 | 5.38 | 52.06 | 5.33 | 52.43 | 1.62 | 55.38 | 4.54 | 54.86 | 5.46 | 55.29 | 3.08 |
| Cond-Pog (mm) | 102.43 | 9.43 | 100.76 | 9.68 | 117.57 | 12.62 | 109.65 | 12.5 | 126.57 | 11.91 | 118.72 | 14.59 |
| Cranial base angle (°) | 124.57 | 4.39 | 119.56 | 4.89 | 123.57 | 1.81 | 120.89 | 4.71 | 124.29 | 5.99 | 120.39 | 4.16 |
| AB/facial plane (°) | 3.57 | 2.7 | 2.5 | 1.92 | 3.29 | 2.43 | 2.5 | 2.01 | 3 | 2.71 | 3.22 | 2.34 |
| Ant:post cranial b | 2.31 | 0.22 | 2.24 | 0.25 | 2.1 | 0.23 | 2.16 | 0.26 | 2.05 | 0.29 | 2.07 | 0.22 |
| NS/Gn (°) | 78.06 | 5.07 | 75.14 | 9.65 | 79.11 | 5.61 | 77.29 | 10.26 | 89.57 | 12.23 | 79.67 | 5.94 |
| AB/OccP (°) | 81 | 5.39 | 83.11 | 4.56 | 85.29 | 5.79 | 85.61 | 3.58 | 79.29 | 8.99 | 84.94 | 4.08 |
| Spa-Me (mm) | 58 | 2.83 | 58.11 | 5.18 | 64.57 | 6.8 | 62.28 | 5.8 | 67.86 | 6.79 | 69 | 6.32 |
| Upper gonial (°) angle | 59.43 | 2.94 | 55.89 | 4.47 | 55.71 | 4.39 | 52 | 3.69 | 52 | 2 | 50.44 | 3.65 |
| Upper-incisor incl. (°) | 101 | 8.25 | 101.17 | 7.2 | 108.57 | 7.81 | 106 | 6.82 | 108 | 13.54 | 106.5 | 8.84 |
| Lower-incisor incl. (°) | 92.14 | 7.9 | 88.28 | 6.8 | 93.43 | 4.58 | 90.61 | 6.98 | 100 | 18.27 | 90.78 | 6.01 |
| S–N:Spp-Spa | 1.42 | 0.07 | 1.37 | 0.22 | 1.48 | 0.12 | 1.35 | 0.13 | 1.38 | 0.15 | 1.37 | 0.12 |
| Go-Me:Spp-Spa | 1.71 | 0.49 | 1.39 | 0.5 | 1.46 | 0.15 | 1.37 | 0.12 | 1.43 | 0.12 | 1.4 | 0.13 |
| Go-Me:S–N | 1.32 | 0.09 | 1.34 | 0.26 | 0.99 | 0.14 | 1.02 | 0.11 | 1.05 | 0.13 | 1.02 | 0.05 |
Parameters showing significant differences between the sucess and failure group (expressed as p-values) to age-matched normal Class I individuals
Tab. 2 Parameter mit statistisch signifanten Unterschieden zwischen der Erfolgs/Misserfolgsgruppe (dargestellt als p-Werte) im Vergleich zu altersgematchten Klasse-I-Patienten
|
|
|
| |
|---|---|---|---|
| MM differential | 0.034 | ||
| Max:MandOccP | 0.008 | ||
| Go-Me | 0.054 | ||
| MaxP/MandP | 0.035 | ||
| Go-Me/SN | 0.010 | ||
| Ar-Go | 0.018 | 0.005 | |
| APDI | 0.026 | 0.022 | |
| FH/S-Gn | 0.033 | ||
| NS-Gn | 0.072 | 0.011 | 0.007 |
| Lower-incisor incl. | 0.017 | ||
| Overjet | 0.035 | 0.017 |
T0 pretreatment, T1 posttreatment, T2 25-year follow-up
Parameters undergoing significantly different developments in the success versus the failure group from T0 to T1 or from T1 to T2.
Tab. 3 Parameter mit signifikant unterschiedlichen Entwicklungen (dargestellt als p-Werte) in der Erfolgs/Misserfolgsgruppe von T0 nach T1 und von T1 nach T2
|
|
| |
|---|---|---|
| MaxP/MandP | – | 0.012 |
| Go-Me/SN | – | 0.011 |
| AB/OccP | – | 0.047 |
| Overjet | – | 0.032 |
T0 pretreatment, T1 posttreatment, T2 25-year follow-up
Results are expressed as p values
Statistically significant pretreatment (T0), posttreatment (T1) and 25-year follow-up (T2) data obtained in the success versus failure group for the four cast-based parameters measured
Tab. 4 Statistisch signifikante Modellbefunde in der Erfolgs- und in der Misserfolgsgruppe zu den Zeitpunkten T0 (vor Therapie), T1 (nach Therapie) und T2 (25 Jahre nach Therapie)
| Pretreatment values ( | Posttreatment values ( | 25-year follow-up ( | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Failure | Success | Failure | Success | Failure | Success | |||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| IMW mand (mm) | 39.00 | 2.65 | 39.46 | 3.60 | 44.33 | 2.52 | 42.63 | 2.13 | 45.00 | 3.16 | 43.14 | 4.61 |
| IMW max (mm) | 41.00 | 1.00 | 42.67 | 3.31 | 48.00 | 1.73 | 48.25 | 1.98 | 49.80 | 3.03 | 48.29 | 2.58 |
| Overbite (mm) | −0.17 | 4.62 | −0.17 | 1.20 | 1.43 | 1.51 | 2.06 | 1.11 | 1.29 | 1.80 | 1.67 | 1.24 |
| Overjet (mm) | −1.83 | 3.54 | −0.56 | 2.57 | −0.71 | 1.80 | 2.33 | 0.69 | −2.29 | 1.50 | 1.89 | 0.76 |
|
|
|
|
| |||||||||
IMW intermolar width
Types of prognathism and treatment success
Tab. 5 Formen der Prognathie und Therapieerfolg
| All patients (100%) | |||||
|---|---|---|---|---|---|
| True mandibular prognathism (32%) | Maxillary retrognathism (13%) | Combined pro- and retrognathism (55%) | |||
| Success | Failure | Success | Failure | Success | Failure |
| 88% | 12% | 100% | 0% | 56% | 44% |